Trexquant Investment LP Makes New Investment in Alpine Immun

Trexquant Investment LP acquired a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 42,773 shares of the biotechnology company’s stock, valued at approximately $440,000. Trexquant Investment LP owned 0.09% of […]

Related Keywords

United States , Canada , American , James Paul Rickey , News Ratings For Alpine Immune Sciences Daily , Ghost Tree Capital , Great Point Partners , Alpine Immune Sciences Inc , Royal Bank , Securities Exchange Commission , American International Group Inc , Quarter For Alpine Immune Sciences , Alpine Immune Sciences Stock Performance , Berenberg Bank , Nasdaq , Exchange Commission , Morgan Stanley , Sg Americas Securities , Alpine Immune Sciences , Trexquant Investment , Free Report , Point Capital Management , International Group , Point Partners , Tree Capital , Immune Sciences , Get Free Report , Alpine Immune Sciences Daily , Nasdaq Alpn , Alpn , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,